<DOC>
	<DOCNO>NCT00074854</DOCNO>
	<brief_summary>The purpose study determine whether CP-547,632 , oral VEGFR-2 tyrosine kinase inhibitor give combination chemotherapy ( carboplatin paclitaxel ) effective treatment advance stage non-small cell lung cancer .</brief_summary>
	<brief_title>A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Histologically cytologically confirm stage IIIB ( inicluding pleural effusion ) , IV recurrent nonsmall cell lung cancer ( nsclc ) . Bidimensionally measurable disease &gt; 2cm x 1 cm conventional CT Scan &gt; 1 cm x 1cm spiral CT Scan . No tumor close proximity major vein artery . No sanguinous pleural effusion due disease pericardial effusion suspicious disease . No evidence history brain metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>